• 05.13.19

    Drug Pricing Transparency Rule: What You Need to Know

    On May 8, the administration issued the much-anticipated final rule requiring drug manufacturers to disclose wholesale acquisition prices in their broadcast advertising.

  • 05.08.19

    Get in the Zone: New Regulations Incent Opportunity Zone Investment

    Final regulations for Opportunity Zone investment have been released. To learn more and about these final regulations and to receive a comprehensive overview of the OZ incentive, click here. On April 17, the long-awaited second set of proposed opportunity zone (OZ) regulations was released ...

  • 05.07.19

    Toward a National Standard: How the CCPA’s Impact Extends Beyond California

    Much has been written about California’s new, robust privacy legislation, which is slated to begin implementation in 2020.

  • 04.25.19

    What Is Changing in Federal Health Insurance Regulation for 2020?

      The annual Notice of Benefit and Payment Parameters from the federal Department of Health and Human Services (HHS) sets key rules for the commercial health insurance market. This year, federal regulators are unusually late in publishing it, so health insurers may need to scramble to ...

  • 04.09.19

    What Do Recent Class Action Changes Mean for Healthcare?

    Healthcare organizations are prime targets for class action lawsuits. The healthcare industry tops the list for class action data breach lawsuits. Healthcare is among the top-three industries facing class action lawsuits around the Telephone Consumer Protection Act (TCPA)—despite a TCPA ...

  • 04.02.19

    What Marketplace and Regulatory Drivers Are Transforming Healthcare M&A?

    The number of healthcare transactions reached a record-smashing 1,738 in 2018. 1 According to a new Capital One poll, mergers and acquisitions are the preferred growth vehicle for 44% of healthcare executives in 2019, indicating that we will continue to see M&A on the rise.

  • 03.27.19

    Ending the Opioid Epidemic: Leading-Edge Responses and Next Steps

      By Jessica Altman, Pennsylvania Insurance Commissioner | Joel Ario, Managing Director, Manatt Health | Patrice Harris, MD, President-Elect, AMA | Susan Kansagra, MD, Section Chief, Chronic Disease and Injury, North Carolina Division of Public Health Between 1999 and 2017, ...

  • 02.14.19

    From Enforcement to Regulation: Legislative Trends for the Tech Industry

    New laws in Europe and California are forcing tech companies to reassess their content or risk big fines. Now, the industry anticipates that more states will enact increasingly tough restrictions. Will there be a shift to more federal legislation that would pre-empt state laws?

  • 02.13.19

    Opportunity Zone Funds Webinar

    Final regulations for Opportunity Zone investment have been released. To learn more and about these final regulations and to receive a comprehensive overview of the OZ incentive, click here. Created by the Tax Cuts and Jobs Act of 2017, opportunity zones are the latest community development ...

  • 01.16.19

    A Framework for Disruptive Innovation

    Join the AHA Center for Health Innovation and Manatt for a new webinar on emerging trends, major players and implications for hospitals and health systems.  In 2018, some of the nation’s most innovative companies launched initiatives large and small to disrupt healthcare’s ...

manatt-black

ATTORNEY ADVERTISING

pursuant to New York DR 2-101(f)

© 2020 Manatt, Phelps & Phillips, LLP.

All rights reserved